JP2014519514A5 - - Google Patents

Download PDF

Info

Publication number
JP2014519514A5
JP2014519514A5 JP2014514581A JP2014514581A JP2014519514A5 JP 2014519514 A5 JP2014519514 A5 JP 2014519514A5 JP 2014514581 A JP2014514581 A JP 2014514581A JP 2014514581 A JP2014514581 A JP 2014514581A JP 2014519514 A5 JP2014519514 A5 JP 2014519514A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
disease
condition
composition according
msdf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014514581A
Other languages
English (en)
Japanese (ja)
Other versions
JP6145089B2 (ja
JP2014519514A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/041054 external-priority patent/WO2012170495A1/en
Publication of JP2014519514A publication Critical patent/JP2014519514A/ja
Publication of JP2014519514A5 publication Critical patent/JP2014519514A5/ja
Application granted granted Critical
Publication of JP6145089B2 publication Critical patent/JP6145089B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014514581A 2011-06-07 2012-06-06 ストロマ細胞由来因子−1のプロテアーゼ耐性変異体を用いた、組織損傷を修復するための方法 Expired - Fee Related JP6145089B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161494079P 2011-06-07 2011-06-07
US61/494,079 2011-06-07
PCT/US2012/041054 WO2012170495A1 (en) 2011-06-07 2012-06-06 Methods for repairing tissue damage using protease-resistant mutants of stromal cell derived factor-1

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017013060A Division JP2017114867A (ja) 2011-06-07 2017-01-27 ストロマ細胞由来因子−1のプロテアーゼ耐性変異体を用いた、組織損傷を修復するための方法

Publications (3)

Publication Number Publication Date
JP2014519514A JP2014519514A (ja) 2014-08-14
JP2014519514A5 true JP2014519514A5 (https=) 2015-04-02
JP6145089B2 JP6145089B2 (ja) 2017-06-07

Family

ID=47296407

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014514581A Expired - Fee Related JP6145089B2 (ja) 2011-06-07 2012-06-06 ストロマ細胞由来因子−1のプロテアーゼ耐性変異体を用いた、組織損傷を修復するための方法
JP2017013060A Pending JP2017114867A (ja) 2011-06-07 2017-01-27 ストロマ細胞由来因子−1のプロテアーゼ耐性変異体を用いた、組織損傷を修復するための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017013060A Pending JP2017114867A (ja) 2011-06-07 2017-01-27 ストロマ細胞由来因子−1のプロテアーゼ耐性変異体を用いた、組織損傷を修復するための方法

Country Status (8)

Country Link
US (1) US10662234B2 (https=)
EP (1) EP2717894B1 (https=)
JP (2) JP6145089B2 (https=)
CN (1) CN103747795A (https=)
AU (2) AU2012268078B2 (https=)
CA (1) CA2838155C (https=)
IL (1) IL229697A0 (https=)
WO (1) WO2012170495A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011106234A1 (en) 2010-02-25 2011-09-01 Provasculon, Inc. Protease-resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
JP6145089B2 (ja) 2011-06-07 2017-06-07 メソブラスト インターナショナル エスエイアールエル ストロマ細胞由来因子−1のプロテアーゼ耐性変異体を用いた、組織損傷を修復するための方法
KR20160096640A (ko) * 2013-12-13 2016-08-16 메조블라스트 인터내셔널 에스에이알엘 기질 세포 유래 인자-1의 프로테아제-내성 돌연변이를 사용한 조직 손상의 복구 방법
JP6532141B2 (ja) * 2014-09-26 2019-06-19 ヘリックスミス カンパニー リミテッド 肝細胞増殖因子及びストローマ細胞由来因子1αを用いた末梢動脈疾患の予防または治療用組成物
CN114366806A (zh) * 2021-12-16 2022-04-19 天津市泌尿外科研究所 一种纳米黑磷负载sdf-1的纳米药物复合体及其制备方法和应用

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171680A (en) 1988-06-14 1992-12-15 Chiron Corporation Superoxide dismutase analogs having novel binding properties
DK0608235T4 (da) 1991-11-13 2005-05-30 A C Thrombosis And Coagulati T Fremgangsmåde til diagnose af blodkoagulationssygdomme
US5670483A (en) 1992-12-28 1997-09-23 Massachusetts Insititute Of Technology Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
CA2117953C (en) 1993-10-14 2001-12-11 Tasuku Honjo Human stromal derived factor 1 alpha and 1 beta and dnas encoding the same
US6852508B1 (en) 1997-02-28 2005-02-08 Genetics Institute, Llc Chemokine with amino-terminal modifications
US6100387A (en) 1997-02-28 2000-08-08 Genetics Institute, Inc. Chimeric polypeptides containing chemokine domains
US6214540B1 (en) 1997-03-26 2001-04-10 University Of Maryland Biotechnology Institute Chemokines that inhibit immunodeficiency virus infection and methods based thereon
JP2002506830A (ja) 1998-03-13 2002-03-05 ザ ユニバーシティ オブ ブリティッシュ コロンビア 治療的ケモカイン受容体アンタゴニスト
CA2305787A1 (en) 2000-05-09 2001-11-09 The University Of British Columbia Cxcr4 antagonist treatment of hematopoietic cells
CA2245224A1 (en) 1998-08-14 2000-02-14 Jiang-Hong Giong Chemokine receptor antagonists and chemotherapeutics
US20020107195A1 (en) 1998-07-21 2002-08-08 Smithkline Beecham Corporation Method for inducing chemotaxis in endothelial cells by administering stromal cell derived factor-1alpha
US6440934B1 (en) * 1998-10-13 2002-08-27 Chiron Corporation Angiogenically effective unit dose of FGF-2 and method of use
BR9915548A (pt) * 1998-10-16 2001-08-14 Biogen Inc Proteìnas de fusão de interferon-beta e usos
US6221856B1 (en) 1999-02-03 2001-04-24 Inologic, Inc. Inositol derivatives for inhibiting superoxide anion production
AU2003901668A0 (en) 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
US7378098B2 (en) 2000-04-12 2008-05-27 The University Of British Columbia CXC chemokine receptor 4 agonist peptides
US20050059584A1 (en) 2002-08-16 2005-03-17 Ahmed Merzouk Novel chemokine mimetics synthesis and their use
US7368425B2 (en) 2006-03-24 2008-05-06 Chemokine Therapeutics Corp. Cyclic peptides for modulating growth of neo-vessels and their use in therapeutic angiogenesis
CA2335109A1 (en) 2000-04-12 2001-10-12 Chemokine Therapeutics Corporation Cxcr4 agonist treatment of hematopoietic cells
DE10027383A1 (de) 2000-06-02 2001-12-20 Rhein Biotech Proz & Prod Gmbh Nukleinsäure-Molekül umfassend eine für ein Chemokin, einen Neuropeptid-Präkursor oder mindestens ein Neuropeptid kodierende Nukleinsäuresequenz
MXPA02012067A (es) 2000-06-05 2004-08-19 Univ Columbia Identificacion y uso de celulas endoteliales precursoras derivadas de medula osea par mejorar la funcion del miocardio despues de dano isquemico.
US7547674B2 (en) 2001-06-06 2009-06-16 New York Medical College Methods and compositions for the repair and/or regeneration of damaged myocardium
WO2002036078A2 (en) 2000-11-05 2002-05-10 University Of Florida Targeting pluripotent stem cells to tissues
WO2002038172A2 (en) 2000-11-09 2002-05-16 Genetics Institute, Llc Sdf-1 beta expressing tumor cells as tumor vaccines
MXPA03004913A (es) 2000-12-01 2003-09-05 Schering Corp Usos de genes de mamifero y reactivos relacionados.
WO2002045717A1 (en) 2000-12-06 2002-06-13 Tularik Inc. Lometrexol combination therapy
US7558611B2 (en) 2001-11-24 2009-07-07 Image Analysis, Inc. Automatic detection and quantification of coronary and aortic calcium
US20030199464A1 (en) 2002-04-23 2003-10-23 Silviu Itescu Regeneration of endogenous myocardial tissue by induction of neovascularization
EP1503786A2 (en) 2002-05-10 2005-02-09 IPF Pharmaceuticals GmbH A method of inhibiting the emigration of cells from the intravascular compartment into tissues
US7485141B2 (en) 2002-05-10 2009-02-03 Cordis Corporation Method of placing a tubular membrane on a structural frame
US20050065064A1 (en) 2002-08-09 2005-03-24 Elias Lolis Identification of allosteric peptide agonists of CXCR4
WO2008121719A1 (en) 2007-03-30 2008-10-09 The Cleveland Clinic Foundation Method of treating ischemic disorders
US20040037811A1 (en) 2002-08-22 2004-02-26 The Cleveland Clinic Foundation Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy
US20050271639A1 (en) 2002-08-22 2005-12-08 Penn Marc S Genetically engineered cells for therapeutic applications
JP2006502142A (ja) 2002-08-23 2006-01-19 ブリストル−マイヤーズ スクイブ カンパニー 虚血性損傷を減少させる方法
US20070060512A1 (en) 2003-03-04 2007-03-15 Homayoun Sadeghi Dipeptidyl-peptidase protected protein
WO2004094465A2 (en) 2003-04-23 2004-11-04 The Board Of Trustees Of The University Of Illinois Office Of Technology Management University Of Illinois At Urbana-Champaign Synthetic molecules that mimic chemokines
WO2006124013A2 (en) 2004-04-30 2006-11-23 Five Prime Therapeutics, Inc. Novel stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof, and method of use
EP1803464A4 (en) 2004-09-17 2009-09-09 Cellgentech Inc TOPICAL PREPARATION FOR THE TREATMENT OF SKIN DISEASES
KR20070085288A (ko) 2004-09-24 2007-08-27 안지오블라스트 시스템스 인코퍼레이티드 간엽 전구세포의 증식 및/또는 생존성 증강 방법
WO2006047315A2 (en) 2004-10-25 2006-05-04 The Brigham And Women's Hospital, Inc. Targeted delivery of biological factors using self-assembling peptide nanofibers
US20060110374A1 (en) 2004-11-24 2006-05-25 Dudy Czeiger Method to accelerate stem cell recruitment and homing
JP2008526749A (ja) 2005-01-04 2008-07-24 ザ ブライハム アンド ウイメンズ ホスピタル, インコーポレイテッド 自己アセンブリするペプチドナノファイバーを用いたpdgfの徐放性の送達
US8153592B2 (en) 2005-01-10 2012-04-10 Mayo Foundation For Medical Education And Research Modulating toll-like receptor activity
DK1879606T3 (da) 2005-04-25 2013-09-23 Massachusetts Inst Technology Selvorganiserende peptider til fremme af hæmostase
JP2009513689A (ja) * 2005-10-31 2009-04-02 ラボラトワール セローノ ソシエテ アノニム 神経学的疾患の治療、及び/又は予防のためのsdf−1の使用
WO2007079460A2 (en) 2006-01-04 2007-07-12 Chemokine Therapeutics Corporation Design of cxc chemokine analogs for the treatment of human diseases
US7776816B2 (en) * 2006-01-20 2010-08-17 Board Of Regents, The University Of Texas System Preserving hypoxic tissue
JP5244785B2 (ja) 2006-08-11 2013-07-24 小野薬品工業株式会社 ストローマ由来因子−1(sdf−1)に対するモノクローナル抗体
US7696309B2 (en) 2006-10-23 2010-04-13 The Brigham And Women's Hospital, Inc. Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
US20080194478A1 (en) 2007-02-09 2008-08-14 Gene Signal International Sa Wound healing agent and composition
ES2325715B1 (es) 2007-08-03 2010-06-17 Genetrix, S.L. Poblacion de celulas madre adultas derivadas de tejido adiposo cardiaco y su uso en regeneracion cardiaca.
EP2210622B1 (en) 2007-10-10 2015-07-08 Kyoto University Therapeutic agent for heart disease, which is intended to be used in cell transplantation therapy
EP2218459B1 (en) * 2007-11-07 2012-02-01 Ono Pharmaceutical Co., Ltd. Sustained release composition containing sdf-1
EP2100954A1 (en) 2008-03-10 2009-09-16 Assistance Publique - Hopitaux de Paris Method for generating primate cardiac progenitor cells for clinical use from primate embryonic stem cells, and their applications
JPWO2010024300A1 (ja) 2008-08-26 2012-01-26 国立大学法人北海道大学 骨充填型軟骨組織再生誘導剤
AU2010249482A1 (en) 2009-05-20 2012-01-12 Board Of Regents, The University Of Texas System Identification of micro-RNAs involved in post-myocardial infarction remodeling and heart failure
WO2010138180A2 (en) * 2009-05-26 2010-12-02 The University Of Vermont And State Agriculture College Compositions and methods for cardiac tissue repair
WO2011106234A1 (en) * 2010-02-25 2011-09-01 Provasculon, Inc. Protease-resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
WO2012027170A1 (en) * 2010-08-23 2012-03-01 Provasculon, Inc. Methods for repairing tissue damage using protease-resistant mutants of stromal cell derived factor-1
WO2012026041A1 (ja) * 2010-08-27 2012-03-01 富士通株式会社 並列計算機、並列計算機のジョブ情報取得プログラム、並列計算機のジョブ情報取得方法、計算装置及び計算管理装置
JP6145089B2 (ja) 2011-06-07 2017-06-07 メソブラスト インターナショナル エスエイアールエル ストロマ細胞由来因子−1のプロテアーゼ耐性変異体を用いた、組織損傷を修復するための方法
KR20160096640A (ko) 2013-12-13 2016-08-16 메조블라스트 인터내셔널 에스에이알엘 기질 세포 유래 인자-1의 프로테아제-내성 돌연변이를 사용한 조직 손상의 복구 방법

Similar Documents

Publication Publication Date Title
JP2017500316A5 (https=)
JP2019519528A5 (https=)
JP2021521230A5 (https=)
JP2014519514A5 (https=)
JP5907970B2 (ja) インターロイキン−22のウイルス性肝炎の治療における応用
JPWO2019156137A5 (https=)
JP2011518179A5 (https=)
JP2012523438A5 (https=)
IL198021A (en) Mutant-resistant mutant cell protease derived from Factor 1 in repair of tissue damage
RU2013139651A (ru) Новые соединения, влияющие на пищевое поведение
JP2011001381A (ja) Glp−1医薬組成物
JP2019533722A5 (https=)
JP2017536337A5 (https=)
JP2006506942A5 (https=)
JP2020535161A5 (https=)
JP2006502702A5 (https=)
JP2016536357A5 (https=)
JP2018521977A5 (https=)
JP2017114867A (ja) ストロマ細胞由来因子−1のプロテアーゼ耐性変異体を用いた、組織損傷を修復するための方法
US12146005B2 (en) Compositions and methods for treatment of fungal infections
WO2015180634A1 (zh) 用于治疗2型糖尿病的长效肠激素多肽类似物及应用
JP2020527546A5 (https=)
JP2017524727A5 (https=)
CN110769843A (zh) C5a受体激动剂肽的盐酸盐
JP2008502323A5 (https=)